Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Shares of ARWR Up 29.0% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on January 8th, 2019 at $14.17. In approximately 1 month, Arrowhead Pharma has returned 29.02% as of today's recent price of $18.28.

ARWR : 18.02 (-0.44%)
Biotech Stocks Rising

Below are several biotech companies in the news you should know

SGMO : 8.54 (+0.95%)
ARWR : 18.02 (-0.44%)
IMMU : 14.31 (-0.35%)
Relatively Good Performance Detected in Shares of Arrowhead Pharma in the Biotechnology Industry (ARWR, SGMO , EPZM , AKBA , MNTA )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

SGMO : 8.54 (+0.95%)
ARWR : 18.02 (-0.44%)
EPZM : 11.72 (-4.09%)
SmarTrend Watching for Potential Pullback in Shares of Arrowhead Pharma After 3.97% Gain

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $14.77 to a high of $16.30. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high...

ARWR : 18.02 (-0.44%)
Arrowhead Pharmaceuticals Reports Fiscal 2019 First Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2019 first quarter ended December 31, 2018. The company is hosting a conference call at 4:30...

ARWR : 18.02 (-0.44%)
Report: Exploring Fundamental Drivers Behind TD Ameritrade Holding, Vertex Pharmaceuticals, Arrowhead Pharmaceuticals, Nucor, Portland General Electric, and TrueBlue -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TD Ameritrade Holding Corporation...

AMTD : 56.19 (-0.83%)
ARWR : 18.02 (-0.44%)
POR : 49.73 (+0.32%)
VRTX : 183.06 (-2.54%)
TBI : 23.45 (-1.01%)
NUE : 61.06 (-0.68%)
Arrowhead Pharmaceuticals to Webcast Fiscal 2019 First Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 7, 2019, at 4:30 p.m. EST to discuss its financial results for the...

ARWR : 18.02 (-0.44%)
Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1 clinical study of ARO-ANG3, an RNAi-based investigational medicine targeting...

ARWR : 18.02 (-0.44%)
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for approval to begin a Phase 1 clinical trial of ARO-APOC3, an RNAi-based investigational medicine...

ARWR : 18.02 (-0.44%)
Downtrend Call Working As Arrowhead Pharma Stock Falls 27.3% (ARWR)

SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on October 5th, 2018 at $15.05. In approximately 3 months, Arrowhead Pharma has returned 27.28% as of today's recent price of $10.95....

ARWR : 18.02 (-0.44%)
Relatively Good Performance Detected in Shares of Arrowhead Pharma in the Biotechnology Industry (ARWR, PTLA , DVAX , ARRY , EXAS )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ARWR : 18.02 (-0.44%)
DVAX : 10.59 (-3.64%)
PTLA : 30.15 (+0.67%)
Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Agios Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / December 12, 2018 / U.S. equities finished lower on Tuesday after bouncing between the red and green territory. The stocks gained more than 1% across the board on improving...

ARWR : 18.02 (-0.44%)
Arrowhead Pharmaceuticals Reports Fiscal 2018 Year End Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2018 fourth quarter and year ended September 30, 2018. The company is hosting a conference call...

ARWR : 18.02 (-0.44%)
J&J Strikes Deal with argenx to Co-Develop Cancer Antibody

Johnson & Johnson (JNJ) inks a global deal with Europe's argenx to jointly develop and globally commercialize the latter's prospective antibody, cusatuzumab.

CELG : 88.65 (-1.94%)
ARWR : 18.02 (-0.44%)
JNJ : 135.42 (-0.68%)
BMY : 50.13 (-2.28%)
Acadia Pharmaceu has the Best Relative Performance in the Biotechnology Industry (ACAD , ARWR, LXRX , NTRA , EXAS )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LXRX : 5.34 (-0.19%)
ARWR : 18.02 (-0.44%)
ACAD : 22.26 (-2.45%)
Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on December 11, 2018, at 4:30 p.m. EST to discuss its financial results for the...

ARWR : 18.02 (-0.44%)
18.3% Return Seen to Date on SmarTrend Arrowhead Pharma Call (ARWR)

SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on October 5th, 2018 at $15.05. In approximately 2 months, Arrowhead Pharma has returned 18.27% as of today's recent price of $12.30....

ARWR : 18.02 (-0.44%)
Radius Health In has the Best Relative Performance in the Biotechnology Industry (RDUS , SGMO , ARRY , ARWR, FLXN )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

SGMO : 8.54 (+0.95%)
ARWR : 18.02 (-0.44%)
ARRY : 22.71 (-1.99%)
RDUS : 18.39 (-2.60%)
Arrowhead Pharmaceuticals Presents Late-Breaking Clinical Data on ARO-AAT at Liver Meeting(R) 2018

--Reductions were sustained for greater than 14 weeks indicating that quarterly or less frequent dosing appears feasible

ARWR : 18.02 (-0.44%)
Arrowhead Pharmaceuticals Presents Late-Breaking Preliminary Clinical Data on ARO-HBV at Liver Meeting(R) 2018

--- ARO-HBV appears to be well-tolerated at monthly doses up to 400 mg

ARWR : 18.02 (-0.44%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX +0.04
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar